The Specimen Acquisition and Distribution Core will be responsible for obtaining, tracking and allocatingblood and tissue samples (colon, ileum, lymph node, plasma and PBMC) for use by the individual projects.The function is critical to the overall development of this PO1 as the Core's support will allow investigators foreach of the projects to focus on the generation of preliminary data derived from specimens provided by theCore. The Core will coordinate tissue procurement at Rush University Medical Center (RUMC), University ofCalifornia-San Francisco (UCSF), and Case Western Reserve University (CWRU), and will overseedistribution of tissue and body fluid samples to Projects 1, 2, and 4. These objectives will be accomplishedby implementing an established internet-based communication system to provide real time display ofavailable specimens and an agile online requisition system. All of the routine collection methods are in placeat each of the sites of this Core. The ongoing data collection systems established at the sites allow for readyidentification of eligible patients who can be scheduled for biopsies within a few weeks. The infrastructurethat is in place at UCSF will allow for the efficient and timely identification of unique and rare patients (e.g.'elite controllers'). Similar systems are in place at the RUMC and CWRU sites for obtaining lymph node andgut tissue samples. In addition to the primary function of the Core in obtaining tissue, the Core will ensurethe availability of cryopreserved cells and plasma specimen obtained at each site, and will process and shipthe urine specimens needed for the intestinal permeability studies of Project 2. The Core will also obtainrelevant clinical information on subjects including current and previous antiretroviral therapy, CD4+ T-cellcounts, HIV-1 RNA levels and co-morbid conditions. The overall specific aims for the Core are:1. Coordinate the timely and efficient acquisition, preparation and transportation of high-quality tissuespecimens from the clinical sites at RUMC, UCSF and CWRU to the appropriate project principalinvestigators.2. Assure that uniform clinical information is obtained at all clinical sites and that standardized datacollection tools are used.3. Maintain a defined set of standardized data on tissue and cell types, and volumes available fordistribution in the repository at all times.4. Track the collective inventory of viably cryopreserved cells and blood specimens at each participating sitefor use within the Program project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI076174-01A1
Application #
7525017
Study Section
Special Emphasis Panel (ZAI1-PRJ-A (J1))
Project Start
2008-08-01
Project End
2013-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
1
Fiscal Year
2008
Total Cost
$352,953
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Castillo-Mancilla, Jose R; Morrow, Mary; Boum, Yap et al. (2018) Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 77:507-513
Carnathan, Diane; Lawson, Benton; Yu, Joana et al. (2018) Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques. J Virol 92:
Freeman, Michael L; Morris, Stephen R; Lederman, Michael M (2017) CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells. Pathog Immun 2:335-351
Siewe, Basile; Nipper, Allison J; Sohn, Haewon et al. (2017) FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects. Front Immunol 8:1339
McGinty, Tara; Mirmonsef, Paria; Mallon, Patrick W G et al. (2016) Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS 11:253-60
Siedner, Mark J; Kim, June-Ho; Nakku, Ruth Sentongo et al. (2016) HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS 30:667-70
Fu, P; Hughes, J; Zeng, G et al. (2016) A comparative investigation of methods for longitudinal data with limits of detection through a case study. Stat Methods Med Res 25:153-66
Luo, Zhenwu; Ma, Lei; Zhang, Lumin et al. (2016) Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine 34:1945-55
Shive, Carey L; Clagett, Brian; McCausland, Marie R et al. (2016) Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection. J Acquir Immune Defic Syndr 71:483-92
Lee, Sulggi A; Mefford, Joel A; Huang, Yong et al. (2016) Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS 30:1807-15

Showing the most recent 10 out of 90 publications